Monographie - Cefiderocol sulfate tosylate

Ultimo aggiornamento :
19/11/2024

Cefiderocol sulfate tosylate

Struttura chimica

Nome commerciale

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Fetcroja

Finlandia, Francia, Germania, Gran Bretagna, Italia, Messico, Spagna, Svezia

Bibliografia : Cefiderocol sulfate tosylate

	tipo	pubblicazione
2093	Laboratorio	Cefiderocol (Fetcroja®)- Summary of Product Characteristics Shionogi B.V. 2020
4528	Rivista	Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N. Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Int J Pharm Compound 2021 ;25,1:52-61
4634	Rivista	Loeuille G, D'Huart E, Vigneron J, Nisse YE, Beiler B, Polo C, Ayari G, Sacrez M, Demoré B, Charmillon A. Stability studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy. Antibiotics 2022 ;11,4: 458
4801	Rivista	Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J. Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration. Am J Health-Syst Pharm 2024 ;51,1:

Mentions Légales